Immunome, Inc. (IMNM)
21.48
+0.30
(+1.42%)
USD |
NASDAQ |
Dec 31, 16:00
21.50
+0.02
(+0.09%)
After-Hours: 20:00
Immunome Total Assets (Quarterly): 299.38M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 114.94B |
| Amphastar Pharmaceuticals, Inc. | 1.666B |
| Relay Therapeutics, Inc. | 670.00M |
| Prelude Therapeutics, Inc. | 94.76M |
| Context Therapeutics, Inc. | 79.23M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 35.46M |
| Shareholders Equity (Quarterly) | 263.92M |
| Debt to Equity Ratio | 0.0152 |
| Current Ratio | 8.902 |
| Net Debt Paydown Yield | -0.02% |